Guobang Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 605507?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	6,250,000	1.13%
Employee Share Scheme	7,839,600	1.42%
Institutions	22,106,248	4%
Individual Insiders	70,754,801	12.8%
General Public	165,057,657	29.9%
Private Companies	280,688,194	50.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 69.77% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
23.3%	Xinchang Ande Trading Co., Ltd.	128,951,976	CN¥2.7b	0%	no data
13.3%	Xinchang Qingyu Investment Development Co., Ltd.	73,296,367	CN¥1.5b	0%	no data
9.92%	Jiajun Qiu	54,852,971	CN¥1.1b	0%	no data
9.05%	Weifang Shiqihui Equity Investment Partnership Enterprise (Limited Partnership)	50,021,196	CN¥1.0b	0%	no data
2.65%	Weifang Hongdehui Equity Investment Partnership Enterprise (Limited Partnership)	14,668,653	CN¥306.0m	0%	no data
1.42%	Guobang Pharma Ltd., ESOP	7,839,600	CN¥163.5m	0%	no data
1.35%	Yaqing Zhu	7,452,666	CN¥155.5m	0%	no data
1.24%	Shaoxing Shangyu State-Owned Capital Investment and Operation Co.,Ltd	6,875,001	CN¥143.4m	0%	no data
1.24%	Shaoxing Jinze Enterprise Management Co., Ltd.	6,875,001	CN¥143.4m	0%	no data
1.13%	Zhejiang Runtu Co., Ltd.	6,250,000	CN¥130.4m	0%	no data
0.9%	Yuda Gong	4,968,560	CN¥103.6m	0%	no data
0.83%	National Council for Social Security Fund	4,586,002	CN¥95.7m	0%	0.01%
0.78%	Haoyu Asset Management (Beijing) Co., Ltd.	4,303,784	CN¥89.8m	0%	no data
0.49%	Penghua Fund Management Co., Ltd.	2,700,464	CN¥56.3m	0%	0.04%
0.31%	Zhongjian Meng	1,740,302	CN¥36.3m	0%	no data
0.31%	Fangfang Lu	1,740,302	CN¥36.3m	0%	no data
0.26%	The Vanguard Group, Inc.	1,427,482	CN¥29.8m	0%	no data
0.24%	Rongtong Fund Management Co. Ltd.	1,310,102	CN¥27.3m	0%	0.09%
0.22%	ICBC Credit Suisse Asset Management Co., Ltd.	1,202,000	CN¥25.1m	0%	0.02%
0.18%	China Southern Asset Management Co., Ltd.	996,100	CN¥20.8m	0%	0.01%
0.17%	Gfund Management Co., Ltd.	947,222	CN¥19.8m	0%	0.07%
0.14%	Dacheng Fund Management Co., Ltd.	762,000	CN¥15.9m	0%	0.01%
0.13%	First State Cinda Fund Management Company Limited	728,600	CN¥15.2m	0%	0.03%
0.1%	China Asset Management Co. Ltd.	576,200	CN¥12.0m	0%	no data
0.099%	Fullgoal Fund Management Co. Ltd.	548,486	CN¥11.4m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/25 10:38
End of Day Share Price	2024/12/25 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guobang Pharma Ltd. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Zhu Chen	Citic Securities Co., Ltd.
Kai Wang	Citic Securities Co., Ltd.
Jiarui Lu	Guosen Securities Co., Ltd.